Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.885 USD | -0.50% | +13.85% | +52.32% |
May. 13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
May. 13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- MarketScreener Strategies